p53 mutation and absence of mdm2 amplification and Ki-ras mutation in 4-hydroxyamino quinoline 1-oxide induced transplantable osteosarcomas in rats

被引:8
作者
Kido, A
Tsujiuchi, T
Tsutsumi, M
Takahama, M
Okajima, E
Kobitsu, K
Miyauchi, Y
Mii, Y
Tamai, S
Konishi, Y
机构
[1] NARA MED UNIV,CTR CANC,DEPT ONCOL PATHOL,KASHIHARA,NARA 634,JAPAN
[2] NARA MED UNIV,DEPT ORTHOPED SURG,KASHIHARA,NARA 634,JAPAN
关键词
p53; mutation; mdm2; Ki-ras; transplantable osteosarcomas; rat;
D O I
10.1016/S0304-3835(96)04537-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previously, we reported the establishment of two transplantable osteosarcomas, one induced by local application of a carcinogen, 4-hydroxyamino quinoline 1-oxide(4-HAQO), and another which developed spontaneously in rats, and their subdivision into four lines with high and low metastatic potential to the lung. In the present study, mutations of p53 and Ki-ras genes were investigated by PCR and SSCP followed by direct sequencing, and the amplification of the mdm2 gene was assessed by Southern blot analysis. Mutations of p53 in exon 7 were detected in 4-HAQO-induced transplantable osteosarcomas, but not their spontaneous counterparts, irrespective of the metastatic potentials. Direct sequencing revealed a CGC to CAC transition with an amino acid change of Arg to His, at codon 246. Neither Ki-ras mutations nor mdm2 amplification were detected in airy of the transplantable tumors. The results suggest that while p53 mutations occurred during osteosarcoma development by 4-HAQO without mdm2 amplification and Ki-ras mutation does not contribute to osteosarcoma development in rats. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 32 条
[21]  
MURAKAMI Y, 1991, CANCER RES, V51, P3356
[22]   SELECTIVE 8-HYDROXYGUANINE FORMATION IN PANCREATIC DNA DUE TO A SINGLE INTRAVENOUS ADMINISTRATION OF 4-HYDROXYAMINOQUINOLINE 1-OXIDE IN RATS [J].
NAKAE, D ;
ANDOH, N ;
MIZUMOTO, Y ;
ENDOH, T ;
SHIMOJI, N ;
HORIGUCHI, K ;
SHIRAIWA, K ;
TAMURA, K ;
DENDA, A ;
KONISHI, Y .
CANCER LETTERS, 1994, 83 (1-2) :97-103
[23]   MDM2 GENE AMPLIFICATION CORRELATES WITH RING CHROMOSOMES IN SOFT-TISSUE TUMORS [J].
NILBERT, M ;
RYDHOLM, A ;
WILLEN, H ;
MITELMAN, F ;
MANDAHL, N .
GENES CHROMOSOMES & CANCER, 1994, 9 (04) :261-265
[24]   ONCOPROTEIN MDM2 CONCEALS THE ACTIVATION DOMAIN OF TUMOR SUPPRESSOR-P53 [J].
OLINER, JD ;
PIETENPOL, JA ;
THIAGALINGAM, S ;
GVURIS, J ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE, 1993, 362 (6423) :857-860
[25]   AMPLIFICATION OF A GENE ENCODING A P53-ASSOCIATED PROTEIN IN HUMAN SARCOMAS [J].
OLINER, JD ;
KINZLER, KW ;
MELTZER, PS ;
GEORGE, DL ;
VOGELSTEIN, B .
NATURE, 1992, 358 (6381) :80-83
[26]   DETECTION OF POLYMORPHISMS OF HUMAN DNA BY GEL-ELECTROPHORESIS AS SINGLE-STRAND CONFORMATION POLYMORPHISMS [J].
ORITA, M ;
IWAHANA, H ;
KANAZAWA, H ;
HAYASHI, K ;
SEKIYA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (08) :2766-2770
[27]   RAPID AND SENSITIVE DETECTION OF POINT MUTATIONS AND DNA POLYMORPHISMS USING THE POLYMERASE CHAIN-REACTION [J].
ORITA, M ;
SUZUKI, Y ;
SEKIYA, T ;
HAYASHI, K .
GENOMICS, 1989, 5 (04) :874-879
[28]  
RAK J, 1995, CANCER RES, V55, P4575
[29]  
Sambrook J., 2002, MOL CLONING LAB MANU
[30]  
TOGUCHIDA J, 1992, CANCER RES, V52, P6194